Press release

Péter Ferdinandy, MD, PhD, MBA, the Founder & CEO of Pharmahungary Group, has been recognized as a ‘Highly Cited Researcher’ for the sixth time in 2023

Further information here.

2023.12.11.

Press release

Péter Ferdinandy, MD, PhD, MBA, Founder & CEO of Pharmahungary Group noticed as ‘Highly Cited Researcher’ for the 5th time and elected as Editor-in-Chief of British Journal of Pharmacology.

Further information here.

2022.11.30.

The main purpose of HBA is to strengthen the position of biotechnology as a strategic industry in Hungary.

In each year HBA organizes special forums which provide opportunities for personal contacts between researchers, investors, companies and government decision-makers.

The forum will continue to bring together the academic, business and public sectors in order to create more efficient and more successful collaborations not only at a national, but also at an international level.

szecskay
bay
77elektronika_logo_2013-jpg
soneas-logo-300x100
creativelaboratory
richter
oncompass
seqomics
softflow
ud-genomed
evonik
tomtec
targetex_bioscience
lipidart
3dhistech
convincive
worldcourier
avicor
biotalentumconsulting1
egis_szlogenes_en-rgb
thalesnanologonew2
logo_hungarotrial
cominnex
humeltis-logo-uj
pharmahungary-new
hyd
tomtec
abiomics
solvo
amgen
pannonpharm
airmax-f-logo_voros-alap-copy
omixon1
cyclolab
tfs_logo_cmyk_ez